Evidence map›Paper›PMID 24098792›Full record

ArticlePloS one2013

The immuno-regulatory impact of orally-administered Hypericum perforatum extract on Balb/C mice inoculated with H1n1 influenza A virus.

Nan Huang, Navrozedeep Singh, Kyoungjin Yoon, Christina M Loiacono, Marian L Kohut, Diane F Birt

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. The mechanisms of action of St. John's wort: an update.Wiener medizinische Wochenschrift (1946) · 2015
    Review
  6. Article
  7. Enhancing the efficacy ofAvicenna journal of phytomedicine
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Nan HuangThe Center for Research on Botanical Dietary Supplements, Iowa State University, Ames, Iowa, United States of America ; Interdepartmental Graduate Program in Nutritional Sciences, Iowa State University, Ames, Iowa, United States of America ; Department of Food Science and Human Nutrition, Iowa State University, Ames, Iowa, United States of America.
Navrozedeep Singh
Kyoungjin Yoon
Christina M Loiacono
Marian L Kohut
Diane F Birt
Iowa State University · USAnimal and Plant Health Inspection Service · US

Funding

THE PURIFICATION,STRUCTURE DETERMINATION AND SYNTHESIS OF BIOACTIVE COMPONENTSP01ES012020 · NIEHS · IOWA STATE UNIVERSITY · PI BIRT, DIANE FEICKERT · 2002 to 2006
$6.9M
SEPARATIONS/STRUCTURE/BIOAVAILABILITY/KRAUS, GEORGEP50AT004155 · NCCIH · IOWA STATE UNIVERSITY · PI BIRT, DIANE FEICKERT · 2007 to 2010
$4.5M
NCCIH NIH HHS P50 AT004155NCCIH NIH HHS P50 AT004155-06NIEHS NIH HHS P01 ES012020
6 · The paper itself

Abstract

Hypericumperforatum (H. perforatum) ethanol extract has been found to inhibit lipopolysaccharide-induced production of inflammatory mediators and cytokines in cultured macrophages. Therefore, it may be able to protect the host from excessive inflammation during viral infection. In the current study, the immune-regulatory effect of H. perforatum extract was evaluated in A549 lung epithelial cells and BALB/c mice exposed to Influenza A/PR/8/34 H1N1 virus. In A549 cells, the extract (30 µg/mL) significantly inhibited influenza virus induced monocyte chemotactic protein (MCP)-1 and interferon-γ induced protein 10 kD (IP-10), but dramatically increased interleukin-6 (IL-6). In mice inoculated intranasally with 10(7.9) EID50 of Influenza A/PR/8/34 H1N1 (high dose), daily oral treatment of H. perforatum extract at a rate of 110 mg/kg of body weight increased lung viral titer, bronchoalveolar lavage (BAL) pro-inflammatory cytokine and chemokine levels, and the infiltration of pro-inflammatory cells in the lung 5 days post-inoculation, as compared to ethanol vehicle treated mice. Transcription of suppressor of cytokine signaling 3 (SOCS3) was increased by H. perforatum extract both in A549 cells and BALB/c mice, which could have interrupted anti-viral immune response and thus led to the inefficient viral clearance and increased lung inflammation. H. perforatum treatment resulted in minor reduction in viral titer without affecting body weight when mice were inoculated with a lower dose (~10(5.0) EID50) and H. perforatum was applied in the later phase of infection. Mice challenged intranasally with high dose of influenza virus (10(7.9) EID50) suffered from a higher mortality rate when dosed with H. perforatum extract. In conclusion, the current study showed that SOCS3 elevation by H. perforatum may cause impaired immune defense against influenza virus infection and lead to higher mortality.

Indexed as

Influenza A Virus, H1N1 SubtypeAdministration, OralAnalysis of VarianceAnimalsBlotting, WesternBronchoalveolar Lavage FluidCell LineChemokine CXCL10ChemokinesCytokinesDNA PrimersEnzyme-Linked Immunosorbent AssayGene Expression RegulationHumansHypericumInterleukin-6Chemokine CXCL10ChemokinesCxcl10 protein, mouseCytokinesDNA PrimersInterleukin-6Monocyte Chemoattractant ProteinsPlant ExtractsSocs3 protein, mouseSuppressor of Cytokine Signaling 3 ProteinSuppressor of Cytokine Signaling Proteins

Identifiers

PMID24098792
PMCPMC3786993
OpenAlexW1970664621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.